カテゴリ： MarketLine, 企業調査, 台湾

Standard Chem & Pharm Co Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4100
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：20
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：台湾
◆産業分野：材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Standard Chem & Pharm Co Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Standard Chem & Pharm Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Standard Chem & Pharm Co Ltd (SCP) manufactures and markets pharmaceutical and healthcare products. The company’s product offerings include pharmaceuticals, supplements, and API. Its drug delivery platforms include osmotic-controlled release oral system, micro-encapsulation, pulsatile controlled release delivery, and lyophilization. SCP develops new products through its R&D facility, Standard Pharmaceutical Research Institute. The company also provides out-licensing and in-licensing services, apart from services and partnership opportunities to research institutes, government agencies, and biotechnology firms to commercialize niche products in the global market. It has business presence in Taiwan, China, Vietnam, Cambodia, Japan, South Korea, Malaysia, the Philippines, and the US. SCP is headquartered in Tainan, Sinying District, Taiwan.

Scope

- Detailed information on Standard Chem & Pharm Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Standard Chem & Pharm Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Standard Chem & Pharm Co Ltd including a breakdown and examination of key business segments
- Intelligence on Standard Chem & Pharm Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Standard Chem & Pharm Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Standard Chem & Pharm Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Standard Chem & Pharm Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Standard Chem & Pharm Co Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Standard Chem & Pharm Co Ltd: Company Overview 6
Standard Chem & Pharm Co Ltd: Overview and Key Facts 6
Standard Chem & Pharm Co Ltd: Overview 6
Standard Chem & Pharm Co Ltd: Key Facts 6
Standard Chem & Pharm Co Ltd: Key Employees 8
Standard Chem & Pharm Co Ltd: Major Products and Services 9
Standard Chem & Pharm Co Ltd: Company History 10
Standard Chem & Pharm Co Ltd: Locations and Subsidiaries 11
Standard Chem & Pharm Co Ltd: Key Competitors 13
Standard Chem & Pharm Co Ltd: Company Analysis 14
Standard Chem & Pharm Co Ltd: Business Description 14
Standard Chem & Pharm Co Ltd: SWOT Analysis 15
Standard Chem & Pharm Co Ltd: SWOT Overview 15
Standard Chem & Pharm Co Ltd: Strengths 15
Standard Chem & Pharm Co Ltd: Weaknesses 16
Standard Chem & Pharm Co Ltd: Opportunities 16
Standard Chem & Pharm Co Ltd: Threats 17
Appendix 18
Contact Us 18
Methodology 18
About MarketLine 19

List of Tables
Table 1: Standard Chem & Pharm Co Ltd: Key Facts
Table 2: Standard Chem & Pharm Co Ltd: Key Employees
Table 3: Standard Chem & Pharm Co Ltd: Locations and Subsidiaries
Table 4: Standard Chem & Pharm Co Ltd: Key Competitors



★海外企業調査レポート[Standard Chem & Pharm Co Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • IRX Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary IRX Therapeutics Inc (IRX Therapeutics) is a clinical-stage bioresearch company that develops immunotherapies which reduces the immune suppression. The company provides product that overcomes cancer induced immune suppression and restores anti-tumor response. It offers product IRX-2 which is …
  • Akonni Biosystems Inc：企業の製品パイプライン分析2018
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray reader …
  • Chr. Hansen Holding AS (CHR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Chr. Hansen Holding A/S (Chr. Hansen) is a bioscience company that focuses on the development of natural ingredient solutions for the food, pharmaceutical, nutritional and agricultural industries. The company develops, produces and markets cultures, enzymes, probiotics and natural colors. It …
  • Immuron Ltd (IMC)-製薬・医療分野：企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …
  • Rio Grande Electric Cooperative, Inc.：企業の戦略的SWOT分析
    Rio Grande Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Warner Media LLC.：企業の戦略・SWOT・財務分析
    Warner Media LLC. - Strategy, SWOT and Corporate Finance Report Summary Warner Media LLC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • China International Marine Containers (Group) Co Ltd：企業のM&A・事業提携・投資動向
    China International Marine Containers (Group) Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China International Marine Containers (Group) Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes busines …
  • enGene Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary enGene Inc (enGene) is a biotechnology company that focuses on transforming medicine by administering gene therapy as an oral drug. The company develops a mucosal immunotherapy platform for treating inflammatory bowel disease and diabetes. It also developed a non-viral gene-therapy platform …
  • Achaogen Inc (AKAO)：企業の財務・戦略的SWOT分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel antibacterial treatments for the treatment of multi-drug resistant and gram-negative infections. The company’s lead product, plazomicin used for the treatment of serious bacterial infecti …
  • Medpace Holdings Inc (MEDP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Medpace Holdings Inc (Medpace) is a scientifically-driven full-service clinical contract research organization. It provides Phase I-IV outsourced clinical development services. The company also offers clinical pharmacology; and supporting laboratory services including central laboratory, bio …
  • Brown Brothers Harriman & Co：企業の戦略的SWOT分析
    Brown Brothers Harriman & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • AXA Egypt：企業の戦略・SWOT・財務情報
    AXA Egypt - Strategy, SWOT and Corporate Finance Report Summary AXA Egypt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Guy’s and St Thomas’ NHS Foundation Trust：企業の戦略的SWOT分析
    Guy's and St Thomas' NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Electricity Generating Public Co Ltd (EGCO)：企業の財務・戦略的SWOT分析
    Electricity Generating Public Co Ltd (EGCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • CytRx Corp (CYTR)：製薬・医療：M&Aディール及び事業提携情報
    Summary CytRx Corp (CytRx) is a clinical state is a biopharmaceutical company focusing on the research and development of novel treatments for cancer. The company’s oncology based product comprises of its lead drug product candidate, aldoxorubicin (formerly INNO-206). Aldoxorubicin is a pro-drug of …
  • Massarella Catering Group Ltd. ：企業の戦略・SWOT・財務情報
    Massarella Catering Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Massarella Catering Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Pacgen Life Science Corp (PBS)-製薬・医療分野：企業M&A・提携分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. Its products include amino-acid antimicrobia …
  • HanAll Biopharma Co Ltd (009420)：企業の財務・戦略的SWOT分析
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for trea …
  • Laboratorio Reig Jofre SA (RJF)：製薬・医療：M&Aディール及び事業提携情報
    Summary Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and consumer healthcar …
  • HICL Infrastructure Co Ltd：企業のM&A・事業提携・投資動向
    HICL Infrastructure Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HICL Infrastructure Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆